Alamy logo

Polymeric nanoparticle Stock Photos and Images

(8)See polymeric nanoparticle stock video clips
Quick filters:

Polymeric nanoparticle Stock Photos and Images

Polymeric nanoparticles for drug encapsulation, illustration Stock Photo
RF2G81REE–Polymeric nanoparticles for drug encapsulation, illustration
3d rendering of Lipid-coated polymeric nanoparticles conjugated poly ethylene glycol for drug delivery Stock Photo
RF2WA1CG6–3d rendering of Lipid-coated polymeric nanoparticles conjugated poly ethylene glycol for drug delivery
Schematic of platelet membrane-coated nanoparticles (PNPs) for the treatment of immune thrombocytopenia purpura (ITP). (A) To fabricate PNPs, the plasma membrane from fresh platelets is derived and then coated onto poly (lactic-co-glycolic acid (PLGA) polymeric nanoparticle cores, transferring the surface antigenic material from the original cells onto the outside of the nanoparticles. (B) Without treatment, ITP is characterized by the binding of pathological autoantibodies to healthy platelets, resulting in their clearance by the reticuloendothelial system. (C) When PNPs are administered, th Stock Photo
RMJ4KCX1–Schematic of platelet membrane-coated nanoparticles (PNPs) for the treatment of immune thrombocytopenia purpura (ITP). (A) To fabricate PNPs, the plasma membrane from fresh platelets is derived and then coated onto poly (lactic-co-glycolic acid (PLGA) polymeric nanoparticle cores, transferring the surface antigenic material from the original cells onto the outside of the nanoparticles. (B) Without treatment, ITP is characterized by the binding of pathological autoantibodies to healthy platelets, resulting in their clearance by the reticuloendothelial system. (C) When PNPs are administered, th
Schematic of platelet membrane-coated nanoparticles (PNPs) for the treatment of immune thrombocytopenia purpura (ITP). (A) To fabricate PNPs, the plasma membrane from fresh platelets is derived and then coated onto poly (lactic-co-glycolic acid (PLGA) polymeric nanoparticle cores, transferring the surface antigenic material from the original cells onto the outside of the nanoparticles. (B) Without treatment, ITP is characterized by the binding of pathological autoantibodies to healthy platelets, resulting in their clearance by the reticuloendothelial system. (C) When PNPs are administered, th Stock Photo
RMP71397–Schematic of platelet membrane-coated nanoparticles (PNPs) for the treatment of immune thrombocytopenia purpura (ITP). (A) To fabricate PNPs, the plasma membrane from fresh platelets is derived and then coated onto poly (lactic-co-glycolic acid (PLGA) polymeric nanoparticle cores, transferring the surface antigenic material from the original cells onto the outside of the nanoparticles. (B) Without treatment, ITP is characterized by the binding of pathological autoantibodies to healthy platelets, resulting in their clearance by the reticuloendothelial system. (C) When PNPs are administered, th
3d rendering of Lipid-coated polymeric nanoparticles conjugated poly ethylene glycol for drug delivery Stock Photo
RF2WA1CG5–3d rendering of Lipid-coated polymeric nanoparticles conjugated poly ethylene glycol for drug delivery
Schematic of platelet membrane-coated nanoparticles (PNPs) for the treatment of immune thrombocytopenia purpura (ITP). (A) To fabricate PNPs, the plasma membrane from fresh platelets is derived and then coated onto poly (lactic-co-glycolic acid (PLGA) polymeric nanoparticle cores, transferring the surface antigenic material from the original cells onto the outside of the nanoparticles. (B) Without treatment, ITP is characterized by the binding of pathological autoantibodies to healthy platelets, resulting in their clearance by the reticuloendothelial system. (C) When PNPs are administered, th Stock Photo
RMR7BRMW–Schematic of platelet membrane-coated nanoparticles (PNPs) for the treatment of immune thrombocytopenia purpura (ITP). (A) To fabricate PNPs, the plasma membrane from fresh platelets is derived and then coated onto poly (lactic-co-glycolic acid (PLGA) polymeric nanoparticle cores, transferring the surface antigenic material from the original cells onto the outside of the nanoparticles. (B) Without treatment, ITP is characterized by the binding of pathological autoantibodies to healthy platelets, resulting in their clearance by the reticuloendothelial system. (C) When PNPs are administered, th
3d rendering of Lipid-coated polymeric nanoparticles conjugated poly ethylene glycol for drug delivery Stock Photo
RF2WA1CG4–3d rendering of Lipid-coated polymeric nanoparticles conjugated poly ethylene glycol for drug delivery
The gold nanoparticle with linker conjugates antibodies, proteins, peptides, ligands, and polymers for specific targeting cells in the blood vessel wi Stock Photo
RF2T71M3X–The gold nanoparticle with linker conjugates antibodies, proteins, peptides, ligands, and polymers for specific targeting cells in the blood vessel wi
Page 1 of 1